1. Home
  2. AZN
  3. AZN News

Latest AstraZeneca PLC (AZN) News on July 26, 2024

FDA committee proposes overhaul of perioperative lung cancer trials
AZN

Pharmaceutical Technology

6 hours ago

FDA committee proposes overhaul of perioperative lung cancer trials

3 Surprisingly Underrated Stocks to Buy Right Now
AZN

Motley Fool

7 hours ago

3 Surprisingly Underrated Stocks to Buy Right Now

Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
AZN

Zacks

9 hours ago

Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News

AZN

Argus Research

12 hours ago

Analyst Report: AstraZeneca PLC

AZN

Argus Research

12 hours ago

Market Digest: SNY, CMCSA, CMG, KLAC, KMB, RCL, UPS, AZN, MSCI, TSLA

Top 3 UK Stocks Estimated To Be Undervalued In July 2024
AZN

Simply Wall St.

16 hours ago

Top 3 UK Stocks Estimated To Be Undervalued In July 2024

AstraZeneca CEO talks dual supply chain strategy
AZN

Yahoo Finance Video

18 hours ago

AstraZeneca CEO talks dual supply chain strategy

AstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment
AZN

Investor's Business Daily

a day ago

AstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment

AZN

Morningstar Research

a day ago

Analyst Report: AstraZeneca PLC

US economy keeps growing, Astrazeneca CEO describes challenges: Catalysts
AZN

Yahoo Finance Video

a day ago

US economy keeps growing, Astrazeneca CEO describes challenges: Catalysts

AstraZeneca CEO: We're building '2 supply chains' to avoid impact of US-China tensions
AZN

Yahoo Finance

a day ago

AstraZeneca CEO: We're building '2 supply chains' to avoid impact of US-China tensions

AZN

MT Newswires

a day ago

Top Midday Stories: US Advance Q2 GDP Rises; Initial Jobless Claims Drop; Ford Earnings Fall; TotalEnergies' Lower Results; AbbVie Raises Guidance; IBM, ServiceNow Report Higher Results

Why AstraZeneca Stock Is Sliding Today
AZN

Motley Fool

a day ago

Why AstraZeneca Stock Is Sliding Today

AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript
AZN

Motley Fool

a day ago

AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript

Why AstraZeneca's CEO isn't worried about costs
AZN

Yahoo Finance Video

a day ago

Why AstraZeneca's CEO isn't worried about costs

Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
AZN

Zacks

a day ago

Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised

NHS rules risk depriving Britain of new medicine, warns AstraZeneca boss
AZN

The Telegraph

a day ago

NHS rules risk depriving Britain of new medicine, warns AstraZeneca boss

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook
AZN

Investor's Business Daily

a day ago

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook

AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines
AZN

Benzinga

a day ago

AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines

AZN

MT Newswires

a day ago

Sector Update: Health Care Stocks Mixed Premarket Thursday

AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales
AZN

Investopedia

a day ago

AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales

AZN

MT Newswires

a day ago

Sector Update: Health Care

Trials to watch: Four biologics concluding pivotal COPD trials
AZN

Clinical Trials Arena

a day ago

Trials to watch: Four biologics concluding pivotal COPD trials

AstraZeneca’s H1 and Q2 2024 Financial Results
AZN

Business Wire

2 days ago

AstraZeneca’s H1 and Q2 2024 Financial Results

AstraZeneca raises full-year outlook as demand for therapies strong
AZN

Reuters

2 days ago

AstraZeneca raises full-year outlook as demand for therapies strong

AstraZeneca grows oncology portfolio with Pinetree’s EGFR degrader
AZN

Pharmaceutical Technology

2 days ago

AstraZeneca grows oncology portfolio with Pinetree’s EGFR degrader

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences
AZN

Zacks

2 days ago

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences

Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
AZN

Benzinga

3 days ago

Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants

AZN

MT Newswires

3 days ago

AstraZeneca Secures Global License for Pinetree's Novel Cancer Candidate

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
AZN

Zacks

3 days ago

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis
AZN

CNW Group

4 days ago

Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis

Is AstraZeneca (AZN) a Portfolio Must-Have Pre-Q2 Earnings?
AZN

Zacks

4 days ago

Is AstraZeneca (AZN) a Portfolio Must-Have Pre-Q2 Earnings?

Enhertu set to become a blockbuster drug after outperforming Kadcyla
AZN

Clinical Trials Arena

5 days ago

Enhertu set to become a blockbuster drug after outperforming Kadcyla

How a single daily pill could soon be the future of losing weight
AZN

The Telegraph

6 days ago

How a single daily pill could soon be the future of losing weight

AstraZeneca (AZN) Stock Rises 18% YTD: Should You Buy?
AZN

Zacks

8 days ago

AstraZeneca (AZN) Stock Rises 18% YTD: Should You Buy?

Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
AZN

Zacks

8 days ago

Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term

Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts
AZN

Zacks

9 days ago

Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts

FDA Accepts Lexicon's (LXRX) NDA for Type I Diabetes Drug
AZN

Zacks

9 days ago

FDA Accepts Lexicon's (LXRX) NDA for Type I Diabetes Drug

Here's Why Astrazeneca (AZN) is a Strong Growth Stock
AZN

Zacks

10 days ago

Here's Why Astrazeneca (AZN) is a Strong Growth Stock

AstraZeneca completes Amolyt Pharma acquisition
AZN

Pharmaceutical Technology

11 days ago

AstraZeneca completes Amolyt Pharma acquisition

AstraZeneca’s Tagrisso gains approval in Canada for NSCLC
AZN

Pharmaceutical Technology

12 days ago

AstraZeneca’s Tagrisso gains approval in Canada for NSCLC

AZN

MT Newswires

15 days ago

Instil Bio Signs Lease With AstraZeneca Pharmaceuticals at California Facility; Shares Rise After Hours

The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
AZN

Zacks

16 days ago

The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian

Three UK Exchange Stocks Estimated To Be Valued Up To 39.2% Below Intrinsic Worth
AZN

Simply Wall St.

16 days ago

Three UK Exchange Stocks Estimated To Be Valued Up To 39.2% Below Intrinsic Worth

Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca
AZN

Zacks

16 days ago

Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca

AstraZeneca PLC (AZN): Is This FTSE Dividend Stock a Good Buy Right Now?
AZN

Insider Monkey

18 days ago

AstraZeneca PLC (AZN): Is This FTSE Dividend Stock a Good Buy Right Now?

The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
AZN

Zacks

19 days ago

The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche

AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
AZN

Clinical Trials Arena

21 days ago

AstraZeneca & Aptamer partner to bolster targeted siRNA therapies

AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
AZN

Pharmaceutical Technology

21 days ago

AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC

AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
AZN

Zacks

21 days ago

AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC

Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
AZN

Zacks

21 days ago

Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD

AZN

MT Newswires

21 days ago

AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer

Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
AZN

Simply Wall St.

21 days ago

Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
AZN

Investor's Business Daily

21 days ago

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
AZN

Zacks

24 days ago

AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use

EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
AZN

Pharmaceutical Technology

25 days ago

EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid

AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
AZN

Benzinga

25 days ago

AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment

AZN

MT Newswires

25 days ago

AstraZeneca's Potential Covid-19 Prevention Drug Gets EU Accelerated Assessment

AZN

MT Newswires

25 days ago

AstraZeneca's Imfinzi, Lynparza Combination Recommended for Approval in Europe as Endometrial Cancer Treatment

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
AZN

Zacks

a month ago

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
AZN

Zacks

a month ago

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN

AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
AZN

Zacks

a month ago

AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer

Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
AZN

Yahoo Finance Video

a month ago

Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst

China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients
AZN

Benzinga

a month ago

China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients

AZN

MT Newswires

a month ago

AstraZeneca Says Tagrisso With Chemotherapy Approved in China

AstraZeneca’s Tagrisso receives approval in Japan for lung cancer
AZN

Pharmaceutical Technology

a month ago

AstraZeneca’s Tagrisso receives approval in Japan for lung cancer

Health Care Roundup: Market Talk
AZN

The Wall Street Journal

a month ago

Health Care Roundup: Market Talk

AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio
AZN

Clinical Trials Arena

a month ago

AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio

AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung Cancer, But Hits Primary Goal In Phase 3 Bladder Cancer Study
AZN

Benzinga

a month ago

AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung Cancer, But Hits Primary Goal In Phase 3 Bladder Cancer Study

AZN

MT Newswires

a month ago

AstraZeneca Says Imfinzi With Chemotherapy Improves Survival in Phase 3 Bladder Cancer Trial

AZN

MT Newswires

a month ago

AstraZeneca's Tagrisso Approved With Chemotherapy in Japan for Lung Cancer Treatment

AZN

MT Newswires

a month ago

AstraZeneca Says Phase 3 Imfinzi Trial in Early-Stage Lung Cancer Misses Primary Endpoint

IMFINZI® (durvalumab) demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial
AZN

Business Wire

a month ago

IMFINZI® (durvalumab) demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial

AstraZeneca’s trial of Imfinzi for lung cancer failed to meet primary endpoint
AZN

Clinical Trials Arena

a month ago

AstraZeneca’s trial of Imfinzi for lung cancer failed to meet primary endpoint

3 No-Brainer Stocks to Buy for Under $100 Right Now
AZN

Motley Fool

a month ago

3 No-Brainer Stocks to Buy for Under $100 Right Now

Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
AZN

Zacks

a month ago

Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs

AstraZeneca’s Truqap and Faslodex combo receives approval in EU
AZN

Pharmaceutical Technology

a month ago

AstraZeneca’s Truqap and Faslodex combo receives approval in EU

AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
AZN

Zacks

a month ago

AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer

AZN

MT Newswires

a month ago

AstraZeneca Says Truqap With Faslodex Combination Approved in EU for Breast Cancer

Why Wall Street Is Chasing Ozempic Wannabes
AZN

The Wall Street Journal

a month ago

Why Wall Street Is Chasing Ozempic Wannabes

AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
AZN

Clinical Trials Arena

a month ago

AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial

Admiral Group And Two Other UK Exchange Stocks Estimated As Undervalued For Investment Consideration
AZN

Simply Wall St.

a month ago

Admiral Group And Two Other UK Exchange Stocks Estimated As Undervalued For Investment Consideration

AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
AZN

Zacks

a month ago

AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
AZN

Benzinga

a month ago

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
AZN

BioPharma Dive

a month ago

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short

One AstraZeneca Insider Raised Stake By 50% In Previous Year
AZN

Simply Wall St.

a month ago

One AstraZeneca Insider Raised Stake By 50% In Previous Year

Astrazeneca (AZN) Stock Sinks As Market Gains: Here's Why
AZN

Zacks

a month ago

Astrazeneca (AZN) Stock Sinks As Market Gains: Here's Why

EHA 2024: AstraZeneca’s Calquence plus chemoimmunotherapy offers new standard for MCL
AZN

Pharmaceutical Technology

a month ago

EHA 2024: AstraZeneca’s Calquence plus chemoimmunotherapy offers new standard for MCL

AstraZeneca's (AZN) Imfinzi Gets FDA Nod in Expanded Use
AZN

Zacks

a month ago

AstraZeneca's (AZN) Imfinzi Gets FDA Nod in Expanded Use

AZN

MT Newswires

a month ago

AstraZeneca Says FDA Approves Imfinzi to Treat Endometrial Cancer

IMFINZI® (durvalumab) plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer
AZN

Business Wire

a month ago

IMFINZI® (durvalumab) plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer

AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval
AZN

Pharmaceutical Technology

a month ago

AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval

AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
AZN

Clinical Trials Arena

a month ago

AstraZeneca reports positive data from Phase III mantle cell lymphoma trial

AZN

MT Newswires

a month ago

AstraZeneca's Blood Cancer Combination Therapy Meets Primary Goal in Late-Stage Study

AstraZeneca/Fibrogen’s Roxadustat FDA Review Further Delayed Following Unanticipated Advisory Committee Request
AZN

Clinical Trials Arena

a month ago

AstraZeneca/Fibrogen’s Roxadustat FDA Review Further Delayed Following Unanticipated Advisory Committee Request

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
AZN

Business Wire

a month ago

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
AZN

Zacks

a month ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
AZN

Zacks

a month ago

Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails

AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
AZN

Yahoo Finance

a month ago

AstraZeneca CFO: 'We've come a long way in our oncology portfolio'

FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
AZN

Zacks

a month ago

FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D

Share on Social Networks: